LORI QUINN: Open Payments
NPI 1497313829 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,894 in 90 payments from 17 companies in 2025. Trend: 2023 $1,416 · 2024 $1,266 · 2025 $1,894
Food & beverage: $1,794Education: $100
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $269 |
| ABBVIE INC. | 17 | $243 |
| Otsuka America Pharmaceutical, Inc. | 9 | $231 |
| Janssen Pharmaceuticals, Inc | 9 | $215 |
| Alkermes, Inc. | 12 | $199 |
| Teva Pharmaceuticals USA, Inc. | 5 | $152 |
| Novartis Pharmaceuticals Corporation | 1 | $139 |
| Neurocrine BioSciences, Inc. | 6 | $127 |
| Axsome Therapeutics, Inc. | 4 | $69 |
| Corium, LLC | 5 | $61 |
Products named: CAPLYTA, VRAYLAR, ARISTADA, SPRAVATO, REXULTI, LEQVIO, INGREZZA, ABILIFY ASIMTUFII.
Industry payments across KY — which companies pay providers there.
